Acadia Healthcare (NASDAQ:ACHC) Trading Up 2.9% - Time to Buy?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s stock price rose 2.9% on Monday . The stock traded as high as $54.15 and last traded at $53.55. Approximately 763,777 shares were traded during trading, a decline of 18% from the average daily volume of 931,295 shares. The stock had previously closed at $52.03.

Analyst Upgrades and Downgrades

A number of analysts recently commented on ACHC shares. Cantor Fitzgerald reiterated a "neutral" rating and issued a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, October 1st. Royal Bank of Canada reissued an "outperform" rating and issued a $94.00 price target on shares of Acadia Healthcare in a research note on Friday, September 20th. KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a "sector weight" rating for the company. Deutsche Bank Aktiengesellschaft upped their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a "hold" rating in a report on Friday, August 2nd. Finally, Barclays decreased their price target on shares of Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating for the company in a report on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat.com, Acadia Healthcare presently has an average rating of "Hold" and an average price target of $86.67.

Acadia Healthcare Trading Up 2.2 %

The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The business's fifty day moving average is $70.74 and its 200-day moving average is $69.47. The firm has a market cap of $4.93 billion, a P/E ratio of -380.86, a price-to-earnings-growth ratio of 1.57 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The company had revenue of $796.00 million during the quarter, compared to the consensus estimate of $784.38 million. During the same quarter last year, the firm posted $0.92 EPS. The company's quarterly revenue was up 8.8% on a year-over-year basis. Analysts predict that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ACHC. Point72 Asset Management L.P. grew its holdings in Acadia Healthcare by 266.0% during the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company's stock worth $153,339,000 after buying an additional 1,650,040 shares in the last quarter. Millennium Management LLC lifted its position in shares of Acadia Healthcare by 3,067.8% during the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company's stock valued at $73,640,000 after purchasing an additional 1,055,894 shares in the last quarter. William Blair Investment Management LLC boosted its holdings in Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company's stock worth $237,434,000 after purchasing an additional 604,070 shares during the last quarter. Vaughan Nelson Investment Management L.P. raised its stake in shares of Acadia Healthcare by 67.9% during the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 733,505 shares of the company's stock worth $49,541,000 after purchasing an additional 296,625 shares during the period. Finally, Principal Financial Group Inc. grew its holdings in Acadia Healthcare by 59.3% during the first quarter. Principal Financial Group Inc. now owns 539,162 shares of the company's stock valued at $42,712,000 after purchasing an additional 200,765 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.